Skip to Main Content

An official website of the United States government

Here you can browse the complete list of publications for studies listed on CDAS.

Publication Year
Title PubMed Authors Journal Year Studies
Body mass index at birth and early life and colorectal cancer: A two-sample Mendelian randomization analysis in European and East Asian genetic similarity populations. 39587448 Papadimitriou N, Murphy N, Jenab M, Chen Z, Brenner H, Kweon SS, Le Marchand L, Moreno V, Platz EA, van Duijnhoven FJB, Cheng I, Pai RK, Phipps AI, Peters U, Zheng W, Hughes DJ Pediatr Obes 2025 PLCO
Associations of blood lipids and LDL cholesterol lowering drug-targets with colorectal cancer risk: a Mendelian randomisation study. 39580580 Chan WC, Liu L, Bouras E, Zuber V, Wen W, Long J, Gill D, Murphy N, Gunter MJ, Assimes TL, Bujanda L, Gruber SB, Küry S, Lynch BM, Qu C, Thomas M, White E, Woods MO, Peters U, Li CI, Chan AT, Brenner H, Tsilidis KK, Zheng W Br J Cancer 2025 PLCO
Characterization of Additive Gene-environment Interactions For Colorectal Cancer Risk. 39316822 Thomas CE, Lin Y, Kim M, Kawaguchi ES, Qu C, Um CY, Lynch BM, Van Guelpen B, Tsilidis K, Carreras-Torres R, van Duijnhoven FJB, Sakoda LC, Campbell PT, Tian Y, Chang-Claude J, Bézieau S, Budiarto A, Palmer JR, Newcomb PA, Casey G, Le Marchandz L, Gi… Epidemiology 2025 PLCO
Effect of Aspirin on Biomarkers of Barrett's Esophagus After Successful Eradication with Radiofrequency Ablation. 39934623 Bresalier RS , Shaheen NJ , Hernandez M , Buttar N , Marcon N , Wani S , Muthusamy R , Falk G , Johnson TT , Yan P , Huo X , Castille TA , Della'Zanna G , Richmond E , Jack Lee J , Brown P , Souza R Dig Dis Sci 2025 EPPT
Inadequate consumption of dietary fatty acids is a risk factor for ovarian cancer: evidence from the prostate, lung, colorectal, and ovarian cancer screening trial. 40106014 Lao J, Wei Y, Liu F, Gong T, Wu Q Eur J Nutr 2025 PLCO
Associations of self-identified race and ethnicity and genetic ancestry with mortality among cancer survivors. 40112084 Vo JB, Brown DW, Buller ID, Shing JZ, Synnott N, Jones RR, Landi MT, Huang WY, Machiela MJ, Berrington De Gonzalez A, Nolan TS, Kraft P, Williams F, Freedman ND J Natl Cancer Inst 2025 PLCO
EEC-GIFT: a fairness-aware machine learning framework for lung cancer screening eligibility using real-world data. 40111867 Conahan P, Robinson LA, Le T, Valdes G, Schabath MB, Byrne MM, Green L, El Naqa I, Luo Y JNCI Cancer Spectr 2025 PLCO
The human oral microbiome and risk of colorectal cancer within three prospective cohort studies in the United States. 40069139 Vogtmann E, Yano Y, Zouiouich S, Hua X, Wan Y, Purandare V, Li S, Dagnall CL, Jones K, Hicks BD, Hutchinson A, Caporaso JG, Wheeler W, Huang WY, Freedman ND, Sandler DP, Beane Freeman LE, Liao LM, Gail MH, Shi J, Abnet CC, Sinha R Cancer 2025 PLCO
Predictive performance of risk prediction models for lung cancer incidence in Western and Asian countries: a systematic review and meta-analysis. 40038330 Juang YR, Ang L, Seow WJ Sci Rep 2025 PLCO
Assessing Lung Cancer Screening Eligibility of Patients With Lung Cancer in the Boston Lung Cancer Study: An Analysis of 7186 Lung Cancer Cases. 39864777 Potter AL, Guo Q, Srinivasan D, Yang ME, McCarthy M, Wang D, Kothari J, Shafer A, Christiani DC, Jeffrey Yang CF Ann Thorac Surg 2025 PLCO
Data augmented lung cancer prediction framework using the nested case control NLST cohort. 40071099 Jiang Y, Manem VSK Front Oncol 2025 NLST
Visual Emphysema as a Category Modifier in Lung-RADS: Secondary Analysis of National Lung Screening Trial. 40049568 Jang S, Kim J, Lee S, Kim YW, Kim J, Lee KW, Lee CT J Am Coll Radiol 2025 NLST
Positive Screens Are More Likely in a National Lung Cancer Screening Registry Than the National Lung Screening Trial. 40023436 Tailor TD, Gutman R, An N, Hoffman RM, Chiles C, Carlos RC, Sicks JD, Gareen IF J Am Coll Radiol 2025 NLST
Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery. 39187984 Downs TM, Bailey HH, Lozar T, Schmitz NS, Green H, Scarlett CO, Havighurst TC, Twaroski K, DeShong K, Wollmer B, Bivalacqua TJ, Saltzstein DR, Shore N, Kim K, Huang W, Ricke WA, Barroilhet L, House M, Parnes HL, Messing E Cancer Prev Res (Phila) 2025
Integration of Germline and Somatic Variation Improves Chronic Lymphocytic Leukemia Risk Stratification. 40305105 Hubbard AK, Brown DW, Liu J, Chan IC, Zhou W, Genovese G, DePaulis A, Srinivasan S, Lin SH, Blechter B, Buller ID, Zeng Q, Cao Y, Huang WY, Freedman ND, Zhang H, Dutta D, Chanock SJ, Bolton KL, Machiela MJ Cancer Res 2025 PLCO
Dietary Fatty Acids and Bladder Cancer Risk: Insights from the PLCO Cancer Screening Trial. 40237627 Li G, Zheng W, Zhang X, Chen Y Nutr Cancer 2025 PLCO
Comorbidity in Midlife and Cancer Outcomes. 40193077 Lavery JA, Boutros PC, Moskowitz CS, Jones LW JAMA Netw Open 2025 PLCO
AutoCOPD-A novel and practical machine learning model for COPD detection using whole-lung inspiratory quantitative CT measurements: a retrospective, multicenter study. 40242563 Lin F, Zhang Z, Wang J, Liang C, Xu J, Zeng X, Zeng Q, Chen H, Zhuang J, Ma Y, Ma Q, Shi R, Xu J, Li Y, Yuan L, Wei X, Wu L, Huang R, Xiao T, Liang W, Zheng J, He J, Liu Y, Liang Z, Zhong N, Lu W EClinicalMedicine 2025 NLST
Model-Based Cost-Utility Analysis of Combined Low-Dose Computed Tomography Screening for Lung Cancer, Chronic Obstructive Pulmonary Disease, and Cardiovascular Disease. 40236262 Behr CM, IJzerman MJ, Kip MMA, Groen HJM, Heuvelmans MA, van den Berge M, van der Harst P, Vonder M, Vliegenthart R, Koffijberg H JTO Clin Res Rep 2025 NLST
Virtual lung screening trial (VLST): An in silico study inspired by the national lung screening trial for lung cancer detection. 40209556 Tushar FI, Vancoillie L, McCabe C, Kavuri A, Dahal L, Harrawood B, Fryling M, Zarei M, Sotoudeh-Paima S, Ho FC, Ghosh D, Harowicz MR, Tailor TD, Luo S, Segars WP, Abadi E, Lafata KJ, Lo JY, Samei E Med Image Anal 2025 NLST